Elsevier

Gene

Volume 754, 5 September 2020, 144855
Gene

Review
Alkaline phosphatase: Structure, expression and its function in bone mineralization

https://doi.org/10.1016/j.gene.2020.144855Get rights and content

Highlights

Abstract

Alkaline phosphatase (ALP) is highly expressed in the cells of mineralized tissue and plays a critical function in the formation of hard tissue. The existing status of this critical enzyme should be reviewed periodically. ALP increases inorganic phosphate local rates and facilitates mineralization as well as reduces the extracellular pyrophosphate concentration, an inhibitor of mineral formation. Mineralization is the production, inside matrix vesicles, of hydroxyapatite crystals that bud from the outer membrane of hypertrophic osteoblasts and chondrocytes. The expansion of hydroxyapatite forms into the extracellular matrix and its accumulation between collagen fibrils is observed. Among various isoforms, the tissue-nonspecific isozyme of ALP (TNAP) is strongly expressed in bone, liver and kidney and plays a key function in the calcification of bones. TNAP hydrolyzes pyrophosphate and supplies inorganic phosphate to enhance mineralization. The biochemical substrates of TNAP are believed to be inorganic pyrophosphate and pyridoxal phosphate. These substrates concentrate in TNAP deficient condition which results in hypophosphatasia. The increased level of ALP expression and development in this environment would undoubtedly provide new and essential information about the fundamental molecular mechanisms of bone formation, offer therapeutic possibilities for the management of bone-related diseases.

Introduction

The extracellular mineralized matrix is a special characteristic of the vertebrate skeletal system. Mineralized tissue functions are not restricted to maintaining the body mass, preserving the internal soft tissues, or even promoting physical movement and mastication; they often act as a conveniently usable source for important minerals that are necessary for several physiological processes. The accumulated minerals are made of calcium phosphate, hydroxyapatite, which is contained in the extracellular matrix. Biochemical mineralization happens in hard tissues such as bone and cartilage, where many tissue-specific cells are involved in this mineralization process. Within bone, osteoblasts that are wrapping the osteoid are accountable for hydroxyapatite production (Murshed, 2018, Karpen, 2018). The reduction in bone density contributing to osteoporosis is attributed to a pathological mineralization deficiency (Ensrud and Crandall, 2017).

Alkaline phosphatase (ALP) [phosphate-monoester phosphohydrolase (alkaline optimum); EC 3.1.3.1] enzyme is encoded by distinct genes as many tissue-specific isozymes. It is found in several organisms (bacteria, plants, and animals) and active in catalyzing phosphomonoester hydrolysis, R-O-PO3, with no respect for category 'R' identification. The catalytic process includes the creation at the active site of serine phosphate that interacts with water at high pH to liberate inorganic phosphate from the enzyme (Holtz and Kantrowitz, 1999, Golub and Boesze-Battaglia, 2007). As the organic alcohol activates the enzyme-bound inorganic phosphate and is phosphorylated, a transphosphorylation reaction occurs in the existence of elevated concentrations of organic alcohol (Han and Coleman, 1995). For vertebrates, the enzyme is an ectoenzyme that is bound covalently to the outer side of cell membrane by a phosphatidyl inositol glycophospholipid anchor connected to the enzyme's C-terminus (Han and Coleman, 1995, López-Delgado et al., 2018). Human beings have four ALP genes referring to the gene components of the intestinal, placental, placental and liver/bone/kidney (nonspecific tissue; TNAP) (Siller and Whyte, 2018). Throughout the various species and tissues where it exists, ALP has several specific roles, although the aim of this analysis is to understand the role of ALP in bone mineralization.

Section snippets

Alkaline phosphatase structure

ALP is a metalloenzyme composed of a number of isoenzymes. Each isoenzymes are membrane attached glycoprotein which is encoded by specific loci genes and are believed to be evolved from a common ancestral gene (Golub and Boesze-Battaglia, 2007). 3 ALP genes are located at chromosome 2 and the fourth one that is L/B/K ALP resides at chromosome 1 as shown in Fig. 1. The nomenclature of these genes is based on the tissue where they are highly expressed and the detail has been tabulated in Table 1.

Alkaline phosphatase expression

The review on gene expression during osteoblastic differentiation and growth plate calcification offers a path to understanding the function of ALP in mineralization. ALP is produced early in growth and is easily found on the surface of the cell and in matrix vesicles of all tissues, bones and calcifying cartilages (Siller and Whyte, 2018). Subsequently, whereas certain genes are upregulated (e.g. osteocalcin), ALP expression reduces. In the initial stages of this process, ALP will obviously

Signaling mechanism in bone cell mineralization

ALP is one of the first functioning genes in the calcification mechanism. At least one of its functions in the mineralization cycle is also expected to take place at an early point. The matrix vesicles are extracelular vesicles of 50–200 nm of diameter invested in membranes, shaped by the polarized budding of chondrocytes and osteoblasts on their surface membrane. This function may require large amounts of intracellular calcium and extracellular phosphate. The lipid content varies from the

ALP initiation of calcium deposition in bone cells

ALP is an echoenzyme hydrolyzing the ester of monophosphate at elevated pH (8–10). Human ALP is categorized into four groups, depending on where they are predominantly expressed, as seen in Table 1. Tissue-nonspecific alkaline phosphatase (TNAP) is found in hypertrophic chondrocytes and osteoblasts cell membranes and often concentrates in those cells on the membranes of matrix vesicles. The biochemical substrates of TNAP shall be assumed to be pyridoxal 5′-phosphate (PLP) (Whyte et al., 1995).

ALP deficiency: Hypophosphatasia

ALPL mutations contribute to defects in TNAP function and, as such, extracellular aggregation of PPI, a normal TNAP substrate and a potent inhibitor of mineralization, are the consequence of hypophosphatasia. Hypophosphatasia also includes rickets, osteomalacia and tooth sludge. Enzyme substitution with minerally-target TNAP from birth avoided extreme hypophosphatasia disease in TNAP−/− knockout mice and then proved that babies and young children with life-threatening hypophosphatasia disease was

Conclusion

Bone mineralization is an essential process of life. Understanding of the underlying mineralization processes is important not only in physiological growth, but also to manage mineralization with deficiency. The recent problem in age related bone mineralization is an alert to the researchers to give more attention on development of prevention method in mineralization deficient and disease related to calcification.

Declaration of Competing Interest

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Acknowledgement

This work was supported by Department of Science and Technology, INSPIRE Faculty Program, Government of India for the research grant to S. Vimalraj (grant no. DST/INSPIRE/04/2017/002913).

References (41)

  • S. Vimalraj et al.

    A Combinatorial effect of carboxymethyl cellulose based scaffold and microRNA-15b on osteoblast differentiation

    Int. J. Biol. Macromol.

    (2016)
  • S. Vimalraj et al.

    Regulation of proliferation and apoptosis in human osteoblastic cells by microRNA-15b

    Int. J. Biol. Macromol.

    (2015)
  • H.C. Anderson

    The role of matrix vesicles in physiological and pathological calcification

    Curr. Opin. Orthop.

    (2007)
  • R.E. Anderson

    Lipid composition of isolated epiphyseal cartilage cells, membranes and matrix vesicles

    Biochim. Biophys. Acta

    (1975)
  • O. Andrukhova et al.

    Augmented fibroblast growth factor-23 secretion in bone locally contributes to impaired bone mineralization in chronic kidney disease in mice

    Front. Endocrinol. (Lausanne)

    (2018)
  • N. Balmain

    Calbindin-D9k. A vitamin-D-dependent, calcium-binding protein in mineralized tissues

    Clin. Orthop. Relat. Res.

    (1991)
  • S. Di Mauro et al.

    Kinetic characterization of hypophosphatasia mutations with physiological substrates

    J. Bone Miner. Res.

    (2002)
  • Ensrud, K.E., Crandall, C.J., 2017. Osteoporosis [published correction appears in Ann. Intern. Med. 2017 Oct...
  • E.E. Golub et al.

    The role of alkaline phosphatase in mineralization

    Curr. Opin. Orthop.

    (2007)
  • C. Halling Linder et al.

    Bone Alkaline Phosphatase and Tartrate-Resistant Acid Phosphatase: Potential Co-regulators of Bone Mineralization

    Calcif Tissue Int.

    (2017)
  • Cited by (395)

    View all citing articles on Scopus
    View full text